Faculty of Medicine, Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany.
German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.
Front Immunol. 2019 Jul 19;10:1706. doi: 10.3389/fimmu.2019.01706. eCollection 2019.
The sphingolipid sphingosine-1-phosphate (S1P) is produced by sphingosine kinases to either signal through intracellular targets or to activate a family of specific G-protein-coupled receptors (S1PR). S1P levels are usually low in peripheral tissues compared to the vasculature, forming a gradient that mediates lymphocyte trafficking. However, S1P levels rise during inflammation in peripheral tissues, thereby affecting resident or recruited immune cells, including macrophages. As macrophages orchestrate initiation and resolution of inflammation, the sphingosine kinase/S1P/S1P-receptor axis emerges as an important determinant of macrophage function in the pathogenesis of inflammatory diseases such as cancer, atherosclerosis, and infection. In this review, we therefore summarize the current knowledge how S1P affects macrophage biology.
鞘脂类神经酰胺-1-磷酸(S1P)由鞘氨醇激酶产生,可通过细胞内靶标信号转导或激活特定的 G 蛋白偶联受体(S1PR)家族。与血管系统相比,S1P 在外周组织中的水平通常较低,形成介导淋巴细胞迁移的梯度。然而,在炎症期间外周组织中 S1P 水平会升高,从而影响驻留或募集的免疫细胞,包括巨噬细胞。由于巨噬细胞在炎症的发生和消退中起协调作用,因此鞘氨醇激酶/S1P/S1P 受体轴成为炎症性疾病(如癌症、动脉粥样硬化和感染)发病机制中影响巨噬细胞功能的重要决定因素。因此,在本综述中,我们总结了 S1P 如何影响巨噬细胞生物学的最新知识。